Selection of prostate cancer therapy strategy under early androgen suppression treatment
From MaRDI portal
Publication:6199715
DOI10.1016/J.CNSNS.2024.107914MaRDI QIDQ6199715FDOQ6199715
Authors: Miaoran Yao, Yongxin Zhang, Wendi Wang 
Publication date: 21 March 2024
Published in: Communications in Nonlinear Science and Numerical Simulation (Search for Journal in Brave)
Recommendations
- Comparison between mathematical models of intermittent androgen suppression for prostate cancer
- Modeling prostate cancer response to continuous versus intermittent androgen ablation therapy
- Mathematical modeling of continuous and intermittent androgen suppression for the treatment of advanced prostate cancer
- A new protocol for intermittent androgen suppression therapy of prostate cancer with unstable saddle-point dynamics
- Optimization therapy by coupling intermittent androgen suppression with impulsive chemotherapy for a prostate cancer model
Medical applications (general) (92C50) Periodic solutions to ordinary differential equations (34C25)
Cites Work
- Development of a mathematical model that predicts the outcome of hormone therapy for prostate cancer
- A mathematical model of intermittent androgen suppression for prostate cancer
- Modeling prostate cancer response to continuous versus intermittent androgen ablation therapy
- Global dynamics of a model of joint hormone treatment with dendritic cell vaccine for prostate cancer
- Analysis of mathematical model of prostate cancer with androgen deprivation therapy
- Dynamical systems in population biology
- Dynamics and implications of models for intermittent androgen suppression therapy
Cited In (1)
This page was built for publication: Selection of prostate cancer therapy strategy under early androgen suppression treatment
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6199715)
